SILVER SPRING, Md.,
April 13, 2012 /PRNewswire/
-- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS:
SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned
subsidiary Healthcare Distribution Specialists, LLC ("HDS") are
pleased to announce that HDS has entered into an advertising and
promotion agreement ("Agreement") with a major pro sports team
based in the state of Arizona (the
"Team") for the marketing of Clotamin. The Agreement is part
of new marketing initiatives to promote and launch Clotamin in 240
Walgreens throughout Arizona.
Under terms of the Agreement, HDS, in conjunction with
Walgreens, will have the right to make use of the Team name and
logo in connection with an in-store Clotamin promotion, including
the prominent placement of counter point-of-sale (POS) displays in
all Walgreens locations in the state of Arizona for the duration of the promotion –
approximately five months, beginning on June
1, 2012.
During the consumer promotion and advertising program, Clotamin
will be featured at Team home games on signage and other marketing
elements throughout the University of
Phoenix Stadium in Glendale, Arizona. Team fans will be
encouraged to visit their local Walgreens location, pick-up an
entry form at the Team vendor display, and register for the
opportunity to experience a Team home game in the comfort of an
exclusive private box. One lucky winner each month (4 total)
will receive a private box for a Team home game, including game
tickets, VIP parking passes, and a food and beverage package for 16
guests. Also included in the exclusive prize package
experience is special personal appearance by the Team
mascot/cheerleaders and 16 team gift bags.
"Similar to our pro sports team deal to market Clotamin with
Walgreens in Oregon, this new
agreement in Arizona is designed
to leverage our advertising capabilities to grow awareness and
acceptance of Clotamin with strong endorsements and strategic
sponsorships," stated Mackie A.
Barch, CEO of Sunpeaks Ventures. "The marketing combination
of pharmacy powerhouse Walgreens and a highly-recognizable pro
sports team is designed to allow us to quickly introduce Clotamin
to a statewide audience of loyal customers and fans. We look
forward to working closely with Walgreens and the Team to make this
a successful product launch and an unforgettable experience for our
contest winners."
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary
Healthcare Distribution Specialists, LLC ("HDS"), is a nationally
focused, value-added distributor of specialty drugs and
over-the-counter ("OTC") branded multivitamins to the healthcare
provider market. HDS also owns and markets Clotamin®, a
specialized over-the-counter multivitamin product designed
exclusively for use by patients also on Warfarin®, a popular blood
thinner that has a long list of known adverse drug and food
interactions.
For additional information, please visit
www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 or
info@sunpeaksventures.com
Safe Harbor Statement
Information in this document constitute forward-looking
statements or statements which may be deemed or construed to be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The words
"forecast", "anticipate", "estimate", "project", "intend",
"expect", "should", "believe", and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to known and unknown risks,
uncertainties and other factors which could cause Sunpeaks
Ventures' actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and
other factors are more fully discussed in Sunpeaks Ventures'
filings with the U.S. Securities and Exchange Commission. All
forward-looking statements attributable to Sunpeaks Ventures herein
are expressly qualified in their entirety by the above-mentioned
cautionary statement. Sunpeaks Ventures disclaims any
obligation to update forward-looking statements contained in this
estimate, except as may be required by law.
SOURCE Sunpeaks Ventures, Inc.